The directory offers vital insights into 1,000 top global pharmaceutical and biotech companies, featuring key management, business activities, and more. It aids market research, strategic planning, ...
E-Biotech® today formally announced the launch of its patent-pending artificial intelligence infrastructure platform for pharmaceutical and GMP compliance, following its public unveiling during a live ...
New Members of the Strengthened Leadership Team Add Decades of Operational Execution, Pipeline Optimization and Transactional ...
Apogee Therapeutics (NASDAQ: APGE) is one of the 17 biotechnology stocks with more than 50% upside. On January 25, Citi analyst Geoff Meacham maintained a Buy rating on Apogee Therapeutics ...
North Carolina, ranked in the top five states for life sciences by Business Facilities, is home to a thriving ecosystem specializing in bio and pharmaceutical manufacturing. Propelled by a low cost of ...
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the best single digit stocks to buy according to analysts. On January 8, Morgan Stanley lowered its price target for Rocket Pharmaceuticals from $7 ...
AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI ...
During the first six months of this year, the pharmaceutical-biotech industry completed construction on a total of 31 new plants and research centers across North America During the first six months ...
We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Ultragenyx Pharmaceutical, Inc. (NASDAQ:RARE) stands ...
DUBLIN--(BUSINESS WIRE)--The "Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results